JOSE
SCHNEIDER FONTAN
CATEDRATICOS DE UNIVERSIDAD
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (22)
2023
-
Ki67 and E-cadherin Are Independent Predictors of Long-term Survival in Endometrial Carcinoma
Anticancer Research, Vol. 43, Núm. 2, pp. 683-687
2021
-
Low birth weight trends in Organisation for Economic Co-operation and Development countries, 2000–2015: economic, health system and demographic conditionings
BMC Pregnancy and Childbirth, Vol. 21, Núm. 1
2016
-
Magnetic resonance imaging for the pre-surgical assessment of endometrial cancer: Results in a routine clinical setting, outside dedicated trials; A cross-sectional study
Anticancer Research, Vol. 36, Núm. 4, pp. 1891-1894
2014
-
Exaggerated placental site/placental site trophoblastic tumor: An underestimated risk factor for emergency peripartum hysterectomy
Clinical and Experimental Obstetrics and Gynecology, Vol. 41, Núm. 6, pp. 638-640
2013
-
Endometriosis and cancer
Endometriosis: A Multidisciplinary Approach (Nova Science Publishers, Inc.), pp. 285-294
-
Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node
European Journal of Cancer, Vol. 49, Núm. 5, pp. 1009-1017
-
Pregnancy after breast cancer: Scientific evidence in the XXI century
Revista de Senologia y Patologia Mamaria
-
The E-cadherin expression vs. tumor cell proliferation paradox in endometrial cancer
Anticancer Research, Vol. 33, Núm. 11, pp. 5091-5096
-
Variation among Spanish teaching hospitals in ductal carcinoma in situ treatment: Results of a national survey
European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 171, Núm. 1, pp. 128-131
2012
-
Patient age and biological aggressiveness of endometrial carcinoma
Anticancer Research, Vol. 32, Núm. 5, pp. 1817-1820
-
Relation between dynamic magnetic resonance imaging with biological and histopathological prognostic factors of invasive breast cancer
Revista de Senologia y Patologia Mamaria, Vol. 25, Núm. 4, pp. 133-138
2011
-
Expression of the apoptosis-related genes Bcl-2 and p53 in clinical samples from endometrial carcinoma patients
Anticancer Research, Vol. 31, Núm. 12, pp. 4191-4193
-
mRNA expression of the putative antimetastatic gene BRMS1 and of apoptosis-related genes in breast cancer
Cancer Genomics and Proteomics, Vol. 8, Núm. 4, pp. 195-197
2010
-
Nup88 expression is associated with myometrial invasion in endometrial carcinoma
International Journal of Gynecological Cancer, Vol. 20, Núm. 5, pp. 804-808
1988
-
Normal pregnancy and delivery two years after adjuvant chemotherapy for grade III immature ovarian teratoma
Gynecologic Oncology, Vol. 29, Núm. 2, pp. 245-249
-
ONKOLOGISCHE ABDOMINALE CHIRURGIE BEI UBER 70JAHRIGEN PATIENTINNEN
Zentralblatt fur Gynakologie, Vol. 110, Núm. 2, pp. 85-89
-
Trial of labor after an earlier cesarean section. A conservative approach
Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 33, Núm. 5, pp. 453-456
1987
-
SECOND-LOOK- UND THIRD-LOOK-LAPAROTOMIEN IN DER VERLAUFSKONTROLLE DES OVARIALKARZINOMS. EIN KRITISCHER RUCKBLICK AUF EINE 6JAHRIGE ERFAHRUNG
Zentralblatt fur Gynakologie, Vol. 109, Núm. 4, pp. 235-242
-
Trial of Labour in Patients with a Prior Caesarean Section and an Intervening Vaginal Delivery
Australian and New Zealand Journal of Obstetrics and Gynaecology, Vol. 27, Núm. 3, pp. 178-179
1986
-
TUBENKARZINOM MIT ZERVIXMETASTASE
Zentralblatt fur Gynakologie, Vol. 108, Núm. 19, pp. 1193-1196